Light therapy in the media

THE WEST AUSTRALIAN

Symbyx CEO Wayne Markman says its technology is delivering cognitive and motor improvements...

View Article

7 News

Miracle' Parkinson's treatment to be trialled in Australia.

Watch Video

2GB RADIO INTERVIEW

A new potential treatment for Parkinson's was showing some very promising results...

Listen Now

THE WEEKEND AUSTRALIAN

Parkinson's: Let there be light. Margaret Jarrett was diagnosed with Parkinson's disease 8 years ago...

Read Article

9 NEWS FEATURES PD IMPROVEMENTS USING SYMBYX LIGHT THERAPY

Ms Chen Ong shares her story of how she started playing the piano again after applying the PDCare Laser.

Read Article

PARKINSON'S NSW

Australian medical technology company SYMBYX has completed its first human trial of the use of laser light therapy to reduce the symptoms of Parkinson’s by targeting the gut-brain axis.

Read Article

PRESS RELEASES

EXPLORE OUR TRIALS

Positive six month Parkinson’s trial of its light therapy helmet

May 10, 2023

SYMBYX Biome, an Australian med-tech business, today announced encouraging results from a Sydney Adventist Hospital (commonly known as the San) trial. These results are the six month follow- up results from a triple-blinded, randomised controlled trial run by the San which investigated the efficacy of the SYMBYX Neuro, a new red/infrared light therapy helmet device on People with Parkinson’s (PWP).

PROMISING SYDNEY ADVENTIST HOSPITAL CLINICAL TRIAL RESULTS FOR PARKINSON’S USING THE SYMBYX NEURO

March 17, 2023

SYMBYX, an Australian medtech company developing light therapies for intractable disease conditions, today announced the results of a Sydney Adventist Hospital (commonly known as the San) triple-blinded, randomised controlled trial investigating the effects of a new red/infrared light therapy helmet on patients living with Parkinson’s Disease.

World First Clinical Trial in Inflammatory Bowel Disease

April 22, 2022

SYMBYX, the Australian medical laser company with the world’s first non-pharmaceutical therapy for Parkinson’s, today announced the start of a ground-breaking clinical trial of laser light therapy (photobiomodulation or PBM) on young adults suffering from IBD.

Pathway to FDA & Health Canada approvals

March, 2022

SYMBYX will begin a major clinical trial in Canada using its proprietary treatment system. It's the first Canadian study to examine efficacy of treatment on Parkinson’s symptoms

International Neurology Journal

August, 2021

SYMBYX, an Australian med-tech company developing laser light therapies to reduce Parkinson’s symptoms, said it welcomed the publication of key findings from its Adelaide clinical trial in the leading BMC Neurology Journal.

Two New Clinical Trials Announced

January 6, 2021

SYMBYX, an Australian medtech developing laser light therapies to reduce the debilitating symptoms of Parkinson’s, has begun preparations for two further clinical trials. One will be conducted in Adelaide and the second in Toronto, Canada.